AI assistant
Life360, Inc. — Director's Dealing 2019
Jul 18, 2019
30724_rns_2019-07-18_36de8e67-ed3a-4d4c-9184-ae1af62cdd4b.pdf
Director's Dealing
Open in viewerOpens in your device viewer
==> picture [144 x 47] intentionally omitted <==
ASX ANNOUNCEMENT
19 July 2019
Amended Appendix 3X documents
Reference is made to the Appendix 3X documents lodged with the ASX on 15 May 2019 following the listing of CDIs by Life360, Inc. (Life360 or the Company) (ASX: 360) on 9 May 2019.
Amended Appendix 3X documents in respect of directors Alex Haro, Chris Hulls and James Synge are attached. The Appendix 3X documents lodged on 15 May 2019 understated the directly held security holdings of these directors. The amended Appendix 3X documents reflect the correct number of security holdings of these directors as disclosed in Section 5.5.4 of Life360’s prospectus dated 29 April 2019.
About Life360
Life360 operates a platform for today’s busy families, bringing them closer together by helping them better know, communicate with and protect the people they care about most. The Company’s core offering, the Life360 mobile app, is a market leading app for families, with features that range from communications to driving safety and location sharing. Life360 is based in San Francisco and has more than 20 million monthly active users (MAU) located in more than 160 countries.
Contacts
For investor enquiries: For media enquiries: Jolanta Masojada, +61 417 261 367, Jim Kelly, +61 412 549 083 [email protected] Courtney Howe, +61 404 310 364
Life360’s CDIs are issued in reliance on the exemption from registration contained in Regulation S of the US Securities Act of 1933 (Securities Act) for offers of securities which are made outside the US. Accordingly, the CDIs, have not been, and will not be, registered under the Securities Act or the laws of any state or other jurisdiction in the US. As a result of relying on the Regulation S exemption, the CDIs are ‘restricted securities’ under Rule 144 of the Securities Act. This means that you are unable to sell the CDIs into the US or to a US person who is not a QIB for the foreseeable future except in very limited circumstances until after the end of the restricted period, unless the re-sale of the CDIs is registered under the Securities Act or an exemption is available. To enforce the above transfer restrictions, all CDIs issued bear a FOR Financial Product designation on the ASX. This designation restricts any CDIs from being sold on ASX to US persons excluding QIBs. However, you are still able to freely transfer your CDIs on ASX to any person other than a US person who is not a QIB. In addition, hedging transactions with regard to the CDIs may only be conducted in accordance with the Securities Act.
Life360, Inc. | ARBN 629 412 942 | 539 Bryant St, Suite 402, San Francisco, CA 94107 | investors.life360.com
Page 1
Appendix 3X Initial Director’s Interest Notice
Rule 3.19A.1
Appendix 3X
Initial Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/9/2001.
Name of entity: Life360, Inc.
ARBN : 629 412 942
We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Alexander (Alex) Haro |
|---|---|
| Date of appointment | 25 June 2014 |
Part 1 - Director’s relevant interests in securities of which the director is the registered holder
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
Number & class of securities
-
1,784,054 shares of common stock ( Shares ) (equivalent to 5,352,162 Chess Depositary Interests ( CDIs ))
-
620,551 options
Part 2 – Director’s relevant interests in securities of which the director is not the registered holder
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
- See chapter 19 for defined terms.
Appendix 3X Page 1
11/3/2002
Appendix 3X Initial Director’s Interest Notice
| Name of holder & nature of interest Note: Provide details of the circumstances giving rise to the relevant interest. ICCA Labs, LLC1 AJS Life360 Holdings 2 LLC2 |
Number & class of Securities 30,635 Shares (equivalent to 91,095 CDIs) 372,842 Shares (equivalent to 1,118,526 CDIs) |
|---|---|
Part 3 – Director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Detail of contract | Not applicable. |
|---|---|
| Nature of interest | Not applicable. |
| Name of registered holder (if issued securities) |
Not applicable. |
| No. and class of securities to which interest relates |
Nil. |
1 Alex Haro is a member of ICCA Labs, LLC, an entity that holds Life360, Inc shares. The number of Shares attributable to Alex Haro by reason of his membership interest in ICCA Labs, LLC is 30,635
2 Alex Haro is a member of AJS Life360 Holdings 2 LLC, an entity that holds Life360, Inc shares. The number of Shares attributable to Alex Haro by reason of his membership interest in AJS Life360 Holdings 2 LLC is 372,842
- See chapter 19 for defined terms.
Appendix 3X Page 2
11/3/2002
Appendix 3X Initial Director’s Interest Notice
Rule 3.19A.1
Appendix 3X
Initial Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/9/2001.
Name of entity: Life360, Inc.
ARBN : 629 412 942
We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Christopher (Chris) Hulls |
|---|---|
| Date of appointment | 17 April 2007 |
Part 1 - Director’s relevant interests in securities of which the director is the registered holder
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
Number & class of securities
-
2,886,552 shares of common stock ( Shares ) (equivalent to 8,659,656 Chess Depositary Interests ( CDIs ))
-
1,478,383 options
Part 2 – Director’s relevant interests in securities of which the director is not the registered holder
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
- See chapter 19 for defined terms.
Appendix 3X Page 1
11/3/2002
Appendix 3X Initial Director’s Interest Notice
| Name of holder & nature of interest Note: Provide details of the circumstances giving rise to the relevant interest. ICCA Labs, LLC1 |
Number & class of Securities 29,960 shares of common stock (equivalent to 89,880 CDIs) |
|---|---|
Part 3 – Director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Detail of contract | Not applicable. |
|---|---|
| Nature of interest | Not applicable. |
| Name of registered holder (if issued securities) |
Not applicable. |
| No. and class of securities to which interest relates |
Nil. |
1 Chris Hulls is a member of ICCA Labs, LLC, an entity that holds Life360, Inc shares. The number of Shares attributable to Chris Hulls by reason of his membership interest in ICCA Labs, LLC is 29,960
- See chapter 19 for defined terms.
Appendix 3X Page 2
11/3/2002
Appendix 3X Initial Director’s Interest Notice
Rule 3.19A.1
Appendix 3X
Initial Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/9/2001.
Name of entity: Life360, Inc.
ARBN : 629 412 942
We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | James Synge |
|---|---|
| Date of appointment | 13 May 2019 |
Part 1 - Director’s relevant interests in securities of which the director is the registered holder
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
Number & class of securities
-
480,347 shares of common stock ( Shares ) (equivalent to 1,441,041 Chess Depositary Interests ( CDIs ))
-
6,250 Restricted Stock Units ( RSUs )
Part 2 – Director’s relevant interests in securities of which the director is not the registered holder
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
- See chapter 19 for defined terms.
Appendix 3X Page 1
11/3/2002
Appendix 3X Initial Director’s Interest Notice
Name of holder & nature of interest Number & class of Securities Note: Provide details of the circumstances giving rise to the relevant interest. 64,379 Shares (equivalent to 193,137 CDIs) ICCA Labs, LLC[1]
Part 3 – Director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Detail of contract | Not applicable. |
|---|---|
| Nature of interest | Not applicable. |
| Name of registered holder (if issued securities) |
Not applicable. |
| No. and class of securities to which interest relates |
Nil. |
1 Carthona Capital FS Pty Ltd (an affiliate of James Synge) is a member of ICCA Labs, LLC, an entity that holds Life360, Inc shares. The number of Shares attributable to James Synge by reason of his membership interest in ICCA Labs, LLC is 64,379
- See chapter 19 for defined terms.
Appendix 3X Page 2
11/3/2002